Conference Coverage Capability For Competitive Intelligence Insights in Gastrointestinal Cancers

Objective: Strategic Monitoring of GI Cancer Developments

A top pharmaceutical company in oncology commissioned DelveInsight to provide real-time conference coverage at ESMO 2025 in Barcelona (Spain), Europe’s premier oncology event. The goal was to gather competitive intelligence on abstracts and data readouts for gastrointestinal (GI) cancers, focusing specifically on dMMR/MSI-H, BRAF mutated, FGFR mutated, and KRAS mutated tumor subtypes.​

DelveInsight prioritized coverage that conveyed both competitor strategies and KOL (Key Opinion Leader) perspectives - directly addressing unmet needs, emerging therapeutics, and interpretations of treatment efficacy in GI oncology.

Our Approach: End-to-End Medical Conference Coverage

Pre-Conference Strategy

• Prepared a comprehensive conference coverage plan and playbook aligning with client priorities.​
• Curated and sorted relevant abstract titles, targeting GI subtypes of high strategic importance.
• Provided pre-conference analysis to highlight key sessions, expected data releases, and competitor activities.

Onsite and Virtual Coverage Execution

• Delivered daily reports and live session monitoring during ESMO 2025 for timely intelligence.
• Captured high-resolution images, video footage, and digital posters for visual documentation.
• Gathered Booth and Poster Intelligence, including Q&A from oral presentations.
• Ensured additional virtual support for stakeholder accessibility and engagement.

Key Conference Deliverables

• Prioritized actionable insights from high-impact sessions and oral presentations.
• Generated day-end reports synthesizing competitor announcements and KOL feedback.
• Facilitated in-depth coverage on trends, data highlights, and treatment landscape evolution.

Post-Conference Value Delivery

High-Impact Strategic Outputs

• Developed an executive summary deck with core findings, trends, and strategic implications for GI oncology therapeutics.
• Provided on-call support and expert presentations to client stakeholders, enabling real-time alignment with business decisions.
• Created a detailed post-conference report - mapping competitive intelligence, new data readouts, and stakeholder opinions on dMMR/MSI-H, BRAF, FGFR, and KRAS mutated GI tumors.

Outcome: Empowering Proactive Competitive Strategy in GI Oncology

DelveInsight’s tailored ESMO 2025 conference coverage equipped the client with vital, up-to-date competitive intelligence. Insights on novel GI cancer therapies, current treatment options, and expert opinions positioned the client to anticipate market shifts and respond dynamically to leading competitors within high-need molecular subtypes. This comprehensive monitoring and reporting strengthened strategic planning and supported evidence-based business initiatives in a fast-moving oncology landscape.